Viewing Study NCT01616303

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-02 @ 8:53 PM
Study NCT ID: NCT01616303
Status: COMPLETED
Last Update Posted: 2020-09-14
First Post: 2012-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Sponsor: Quest PharmaTech Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian View
None cancer View
None neoplasm View
None adenocarcinoma View
None CA125 View